China Medicine Industry Limited

Yes. Pursuant to the statutory registers of the Hong Kong Companies Registry, China Medicine Industry Limited was officially incorporated on 2011-02-28 as a Public company limited by shares (standing for 15 years). Official cross-departmental records confirm its current legal status is [Live / In Operation], maintaining valid operational standing under Hong Kong law (Verified: October 2026).

Under Hong Kong's Unique Business Identifier (UBI) regime, China Medicine Industry Limited is identified by two official registration numbers: its 8-digit Business Registration Number (BRN / UBI) [58013114] administered by the Inland Revenue Department, and its 7-digit Company Registration Number (CRN) [1566531] maintained by the Companies Registry for historical statutory filings.

Pursuant to Sections 627 and 643 of the Hong Kong Companies Ordinance (Cap. 622), the equity ownership and executive board of China Medicine Industry Limited are governed by its statutory Register of Members and Register of Directors. Any appointment or resignation of directors or the company secretary must be filed within 15 days via Form ND2A, while complete shareholder equity ratios are disclosed annually in Form NAR1. Furthermore, under Section 653H of Cap. 622, the company must maintain a Significant Controllers Register (SCR) for persons holding over 25% beneficial interest or voting rights.

Yes. According to the official statutory records of the Hong Kong Companies Registry, China Medicine Industry Limited has officially recorded 2 legal name change(s): [L'Oreal (HK) Commodity Group Co., Limited (歐萊雅(香港)日用品集團有限公司) (effective 2011-02-28)], [Company Registration Number 1566531 Limited (公司註冊編號 1566531 有限公司) (effective 2011-11-30)]. Pursuant to Sections 107 and 109 of the Companies Ordinance (Cap. 622), each name change was passed by special resolution (Form NNC2) and took statutory effect upon issuance of a Certificate of Change of Name by the Registrar of Companies; under Section 109(4), changing the company name does not affect any rights, obligations, or legal proceedings of the company.

Official records of the Hong Kong Companies Registry verify that China Medicine Industry Limited maintains a cumulative statutory archive of 20 filing record(s) on file (latest statutory filing indexed on 2026-02-28: Form NAR1 - Annual Return (2026) (Chinese)). Under Section 662 of the Companies Ordinance (Cap. 622), the corporation's active governance and equity standing are documented through Annual Returns (Form NAR1), constitutional Articles of Association (A&A), and statutory officer or capital update filings (Form ND2A / Form NSC1), all accessible as official barcoded image dossiers.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Statutory Licensing Standing: Screened against Hong Kong's statutory licensing databases (SFC Public Register, HKMA Register, TCSP Registry, and Customs MSO), China Medicine Industry Limited is registered as an ordinary commercial company without regulated financial activity licensing requirements; 2. Judicial Screening (Litigation & Winding-Up): public court records screening identified 1 public court docket(s) associated with this corporation; confirmed no compulsory winding-up petitions (HCCW) on file. Specific court levels (High Court HCA / District Court DCCJ), case numbers, party capacities, and judgments are accessible via official Due Diligence Reports.

Official filings of the Hong Kong Companies Registry record the statutory registered office of China Medicine Industry Limited at: [ROOM 3, 6/F, KAM HON INDUSTRIAL BUILDING, 8 WANG KWUN ROAD, KOWLOON BAY, HONG KONG]. Under Section 658 of the Companies Ordinance (Cap. 622), a document or court writ may be lawfully served on a company by leaving it at, or sending it by post to, this registered office. Where the address is domiciled at a licensed TCSP company secretary's premises, Cap. 622B Section 3 permits statutory name display via a compliant electronic signboard system.

Unlike jurisdictions with government ICP domain licensing, Hong Kong regulates corporate identity disclosure under Section 4 of the Companies (Disclosure of Company Name and Liability Status) Regulation (Cap. 622B): China Medicine Industry Limited must legibly display its exact registered name on all business letters, contracts, invoices, and any company website, and report its website (if any) in its Annual Return (Form NAR1) or Form NR2. To prevent cross-border impersonation, trade partners should authenticate the company's legal standing via its statutory identifiers (CRN: 1566531 / 8-digit BRN: 58013114) and barcoded Companies Registry dossiers rather than unverified external web pages.